Articles


Home


Article


Blog

test

Overview

Baselodge Group is a manufacturers’ representative firm bringing together companies that need to outsource design, R&D, manufacturing, and/or related services with top suppliers that excel as outsourcing providers.

We understand the benefits and challenges of outsourcing as well as the critical nature of your supply chain. Our professional staff is committed to building lasting relationships that are mutually beneficial for our customers, our suppliers, and for Baselodge.

Why the name Baselodge?

The base lodge is the warm inviting building at the bottom of the slopes where you rest, relax, refresh, plan, coordinate with others, and from which you embark on your next challenge. Baselodge is a fitting metaphor for the calm determination required to tackle the complex issues of outsourcing.

Overview

Pharmasourcing at Baselodge Group began in 2007 to accommodate today’s dynamic pharmaceutical and nutraceutical landscape, in which drug discovery & development companies may need to leverage their core expertise to provide the infrastructure, personnel, and other resources necessary to bring a product to market. Similarly, as a sea change occurs in the manufacturing sector for large manufacturers with excess capacity, and as dedicated outsource providers seek to grow their revenues, a novel approach to connecting these members of the supply chain is being introduced into this space.

Borrowing from the mature—and established—electronics manufacturing services paradigm at Baselodge, the company is currently in the process of providing the education and information necessary to both contract manufacturers and their potential customers for the mutual benefit of these sometimes disconnected members of the supplement and drug development continuum.

Our success in pharmasourcing at Baselodge Group is based on our ability to establish business relationships among potential partners whereby both customer and supplier recognize the value of the mutually beneficial relationship. In its early stages, this requires education of customers and service suppliers of the value of the manufacturer’s representative paradigm that works exceedingly well in the analogous space of electronics manufacturing services.

If you are a drug or supplement development company in need of contract research or manufacturing services, project consultation, or if you are a contract research or manufacturing firm looking to grow your sales, please Contact Us using the link at the top of this page.

Overview

Baselodge Group is a manufacturers’ rep firm that specializes in contract manufacturing and electronics-related services. Our background in product development and manufacturing provides us with an understanding of the development cycles and customers’ specific needs at different stages.

Whether your outsourcing plans require domestic or offshore production, our suppliers are positioned to help you with the manufacturing of your electronics (PCB & PCBA), flex circuits, plastics, thixomolding, keypads, membrane switches, elastomeric connectors, cable assemblies, metal casting, sub-assemblies, final assemblies (box-builds), and power cords and cordsets.

Our experience includes serving many different vertical markets:

  • Computers & Peripherals
  • Telecommunications & Networking
  • Industrial Automation & Controls
  • Medical Instruments & Devices
  • Oil & Gas
  • Semiconductor & ATE
  • Analytical Devices
  • Consumer ProductsHVAC
  • Military & Aerospace

If you would like for us to provide a quote for your project or if you would like to discuss how it might be a fit for Baselodge Group, please use the Contact Us link at the top of this page

Staff


The Rep’s Role

How does a manufacturers’ representative differ from a direct sales rep?

Manufacturers’ representatives are under contract with the manufacturer to sell and service accounts in their territory. The manufacturer incurs no expense for marketing until their product is sold. The representative is then paid a commission based on the net price of the sale after the manufacturer has been paid by the customer. The biggest difference between a manufacturers’ representative and a direct sales force is the expense incurred by the manufacturer. They are obligated to pay a direct sales force whether they sell anything or not. This fixed expense is then passed on to the customer.

Isn’t it better to deal directly with the manufacturer?

We are direct extensions of our manufacturers. As commissioned sales people, we are more strongly motivated to handle all your problems in a timely manner than someone who is on salary might be. We take a very personal interest in the success of your project and are dedicated to making your experience with Baselodge Group and our manufacturers one that will keep you coming back to us for your future projects.

Aren’t a representative and a distributor the same thing?

In a word, no. Distributors may sell many different brands of any given part and keep parts in stock. A representative sells exclusively for one manufacturer and does not stock anything.

How do I know that you are a reputable company and that I can trust you?

  • Baselodge Group personnel bring more than sixteen years of professional sales experience to both customers and manufacturers.
  • We are dedicated to living up to the reputation we have built for exceptional quality and service.
  • Most of our relationships with customers are under a non-disclosure agreement (NDA).
  • Our desire is for a long-term mutually beneficial relationship. It can only be long-term if we rigorously keep our promises and offer outstanding customer service.

Contract Manufacturing

All companies that manufacture products must face the question “Make or buy?” There are advantages and disadvantages to both methods. When companies decide that “buy” is the right decision for them, they enter the world of contract manufacturing (CM).

Outsourcing is used extensively in many different industries. A few examples are:

  • Electronics Manufacturing Services (EMS)
  • Biotech & Pharmaceutical Manufacturing
  • Information technology

Here are some basic definitions of Contract Manufacturing:

  • Outsourcing; contracting a third party to manufacture some or all of a production line
  • The production of products/formulas on behalf of a client, in which the design and brand name belongs to the client.

While at one time original equipment manufacturers (OEMs) and drug development companies tried to be as vertically integrated as possible, many have decided that manufacturing (at least certain types of manufacturing) is not their core competency. Instead, many companies have turned to CMs whose core competencies are specific types of manufacturing.

Here is a definition of the term Contract Manufacturer:

A company that engages in product analysis, design and development, manufacturing, testing, order fulfillment and product distribution, for another company, on a contract basis.

Allowing a CM to manufacture some or all of a product frees the OEM to operate more price competitively and to focus on the development of their intellectual property (IP), which most feel is their core and distinctive competency. Eliminating the overhead of building and maintaining their own factory, OEMs and drug development firms can put their capital to work in more profitable areas. In addition to conservation of capital, contract manufacturing allows customers to scale their production rapidly. If the customer needed 10,000 units this month, but forecasts a need for 20,000 units next month, a new forecast is submitted to the CM which drives purchasing of the raw materials and components necessary to fulfill that new order. Conversely, if the forecast drops from 10,000 units to 5,000 units, the CM is notified through a new forecast. Employment scaling up and down is reserved for the CM to manage.

What about my IP and/or formulas? CMs sign confidentiality agreements (usually wrapped into the manufacturing contracts) that protect the customer’s IP and formulas. The CM has no claim on your products. They strictly serve as your outsourced factory. Any CM that engages in illegal or unethical activity destroys their reputation and pays a very high penalty for their actions.

There are thousands of CMs offering manufacturing services in both the EMS and Pharmasourcing fields. As an independent manufacturers’ rep, Baselodge Group represents some of the most capable CMs in the world. Let us match you up with our manufacturers to provide you with a quotation for the production of your products.

Maegan Schneider

Maegan SchneiderMaegan is the Customer Support Specialist for Baselodge Group. She works with customers on issues related to quoting, purchase orders, shipping, quality, accounts receivable, and accounts payable.

Schneider earned her Bachelor’s degree from The University of Texas at Austin and is also an accomplished musician and music teacher. She is a native of Baytown, TX, and has been married to her husband, Ben, for six years. They reside in Leander, TX, with their son, Kaiden.

mschneider@baselodge.com 

Samuel F. Lockwood, MD

Dr. Sam LockwoodDr. Lockwood joined the staff of Baselodge Group in 2007 to guide and develop the company’s biotechnology and pharmaceutical outsourcing business.  He is available through Baselodge Group for consulting on any aspect of the nutraceutical and pharmaceutical development process.

Dr. Lockwood is a world-recognized expert in reactive oxygen species (ROS)-mediated disease and was most recently Chief Scientific Officer (CSO) and Co-Founder of Cardax Pharmaceuticals, Inc., a Hawaii-based drug discovery and development company. Dr. Lockwood has eighteen years of industry and clinical experience. Before co-founding Cardax Pharmaceuticals, Dr. Lockwood served as Medical Director for the private company Hawaii Biotech, Inc. (2002-2006), and the public biotech company Aquasearch, Inc. (2000-2002; now Mera Pharmaceuticals, Inc.). Dr. Lockwood received Bachelor of Science degrees in Biology and Psychology from the University of Dayton, Dayton, Ohio; Master of Science degree in Evolutionary Genetics from Texas A&M University, College Station, Texas; and an M.D. from UTMB-Galveston, Texas with subsequent training in Emergency Medicine and Radiology.

Dr. Lockwood is primary inventor (see issued U.S. patents and global patents pending) on Cardax Pharmaceutical’s anti-inflammatory technology, and has co-authored more than 60 peer-reviewed articles, including multiple review articles and book chapters.

An extensive list of Dr. Lockwood’s publications, patents, and patent applications can be found on the Pharmasourcing page of this site. For reprints of scientific articles, please contact Dr. Lockwood at slockwood@baselodge.com.

Mark L. Casey

Mark CaseyMark is the founder and president of Baselodge Group. He currently leads the company’s sales efforts, corporate vision, and growth strategy. He is also principal author at Artful Sourcing.

Casey has more than sixteen years of experience in sales and business development with an emphasis on contract electronics manufacturing. Prior to founding Baselodge Group, Casey was in business development with KeyTronicEMS, Tonbu, and Flextronics International. His diverse background also includes serving as president of an educational technology sales firm, working in software sales, and doing software development for a Fortune 100 company. Prior to moving to Austin, TX, in 1991, Casey also founded, operated, and sold Margot’s Frozen Yogurt, Inc. in Santa Fe, NM.

Casey earned his BBA from The University of Texas at Austin and graduated from The Aji Network’s Sales Professionals Course. He is a native of Baytown, TX, and has been married to his wife, Margot, for 27 years. They reside in Austin, TX, with their two children, Kellen and Matt.

mcasey@baselodge.com

Packaging


Research & Development


Services

In the fulfillment of its mission as outsourcing specialists, Baselodge Group’s pharmasourcing business is focused on helping drug discovery and development companies bring their products to market. The services that we offer, or will offer, in addition to project consulting include the following:

  • CHEMISTRY
    • Fine chemicals (small volumes/weights)
    • Fine chemicals (large volumes/weights)
  • FORMULATION
    • Solid/liquids/creams/gels
  • CONTRACT RESEARCH
    • Preclinical
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • PRODUCT FORMULATION
    • Tablets
    • Tablet coating
    • Time-released tablets
    • Gelcaps
    • Capsules
    • Liquid Production
    • Semi-liquid Production
    • Solid Production
    • Injectibles
    • Creams
    • Analytical lab services
  • CONTRACT PACKAGING
    • Unit dose
    • Bottles
    • Tube filling
    • Vials
    • Foils

Design

Design is the life-blood of great OEMs. As more and more firms have outsourced their manufacturing, they have realized that their true differentiation in the marketplace is in their intellectual property (IP) and in their design capability. At the same time, budget realities have forced many firms to hold the line on engineering staff size or even to downsize their design group. This creates a need for outside design help.

Baselodge Group’s design partners offer design support services to augment your design team. Whether your design team needs a few resources to bridge the gap on a current project or a stand alone design group to manage your project from end-to-end, we can help.

Our designers are committed to protecting your IP, understanding your requirements, designing to your specifications, and interacting with you for design reviews throughout the design cycle. We are experts on design for manufacturability (DFM), design for test (DFT), and design for cost reduction.

Contact Us

Baselodge Group

Main
(512) 535-5233
Fax
(512) 535-7573
Email
info@baselodge.com


About Baselodge


Geography


Line Card


Samuel F. Lockwood, MD

On this page you will find Dr. Lockwood’s selected publications, issued U.S. patents, and published patent applications.

For reprints of scientific articles, please contact Dr. Lockwood at slockwood@baselodge.com.

Dr. Lockwood’s bio can be found here.

Selected Publications top

Issued U.S. Patents top

  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L. M, Jackson, H., Nadolski, G. 2006-12-05. Structural carotenoid analogs for the inhibition and amelioration of disease. US 7,145,025. Assignee Hawaii Biotech Inc. Originally published Aug. 19, 2004.
  • Lockwood, S. F., Tang, P. C., Nadolski, G. T., Jackson, H. L., Fang, Z., Du, Y., Yang, M., Geiss, W. B., Williams, R., Burdick, D. C. 2007-07-24. Methods for the synthesis of astaxanthin. US 7,247,752. Assignee: Cardax Pharmaceuticals, Inc. Originally published Apr. 27, 2006.
  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L. M., Jackson, H., Nadolski, G.  2008-01-08.  Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury.  US 7,317,008.  Assignee Cardax Pharmaceuticals, Inc.  Originally published Feb. 17, 2005.
  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L. M., Jackson, H., Nadolski, G.  2008-01-22.  Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease.  US 7,320,997.  Assignee Cardax Pharmaceuticals, Inc.  Originally published Apr. 7, 2005.
  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L., Jackson, H., Nadolski, G.  2008-03-18.  Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease.  US 7,345,091.  Assignee Cardax Pharmaceuticals, Inc.  Originally published Jan. 13, 2005.
  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L. M., Jackson, H., Nadolski, G.  2008-05-20.  Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease.  US 7,375,133.  Assignee Cardax Pharmaceuticals, Inc.  Originally published Mar. 24, 2005.

Published U.S. and World Patent Applications top

  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L., Jackson, H. L., Nadolski, G. 2005. Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease. US 2005/0004235. Assignee Hawaii Biotech Inc. Published Jan. 6, 2005.
  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L., Jackson, H. L., Nadolski, G. 2005. Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease. US 2005/0009758. Assignee Hawaii Biotech Inc. Published Jan. 13, 2005.
  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L., Jackson, H. L., Nadolski, G. 2005. Carotenoid ester analogs or derivatives for controlling connexin 43 expression. US 2005/0009788. Assignee Hawaii Biotech Inc. Published Jan. 13, 2005.
  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L., Jackson, H. L., Nadolski, G. 2005. Carotenoid analogs or derivatives for controlling connexin 43 expression. US 2005/0009930. Assignee Hawaii Biotech Inc. Published Jan. 13, 2005.
  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L., Jackson, H. L., Nadolski, G. 2005. Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease. US 2005/0026874. Assignee Hawaii Biotech Inc. Published Feb. 3, 2005.
  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L., Jackson, H. L., Nadolski, G. 2005. Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury. US 2005/0037995. Assignee Hawaii Biotech Inc. Published Feb. 17, 2005.
  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L., Jackson, H. L., Nadolski, G. 2005. Carotenoid ether analogs or derivatives for controlling C-reactive protein levels. US 2005/0049248. Assignee Hawaii Biotech Inc. Published Mar. 3, 2005.
  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L., Jackson, H. L., Nadolski, G. 2005. Carotenoid ester analogs or derivatives for controlling C-reactive protein levels. US 2005/0059635. Assignee Hawaii Biotech Inc. Published Mar. 17, 2005.
  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L., Jackson, H. L., Nadolski, G. 2005. Carotenoid analogs or derivatives for controlling C-reactive protein levels. US 2005/0059659. Assignee Hawaii Biotech Inc. Published Mar. 17, 2005.
  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L., Jackson, H. L., Nadolski, G. 2005. Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease. US 2005/0065096. Assignee Hawaii Biotech Inc. Published Mar. 24, 2005.
  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L., Jackson, H. L., Nadolski, G. 2005. Carotenoid ether analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury. US 2005/0065097. Assignee Hawaii Biotech Inc. Published Mar. 24, 2005.
  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L., Jackson, H. L., Nadolski, G. 2005. Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease. US 2005/0075316. Assignee Hawaii Biotech Inc. Published Apr. 7, 2005.
  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L., Jackson, H. L., Nadolski, G. 2005. Pharmaceutical compositions including carotenoid analogs or derivatives for the inhibition and amelioration of disease. US 2005/0075337. Assignee Hawaii Biotech Inc. Published Apr. 7, 2005.
  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L., Jackson, H. L., Nadolski, G. 2005. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease. US 2005/0090469. Assignee Hawaii Biotech Inc. Published Apr. 28, 2005.
  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L., Jackson, H. L., Nadolski, G. 2005. Carotenoid analogs or derivatives for the inhibition and amelioration of disease. US 2005/0113372. Hawaii Biotech Inc. Published May 26, 2005.
  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L., Jackson, H. L., Nadolski, G. 2005. Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury. US 2005/0143475. Assignee Hawaii Biotech Inc. Published Jun. 30, 2005.
  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L., Jackson, H. L., Nadolski, G. 2005. Carotenoid ether analogs or derivatives for controlling connexin 43 expression. US 2005/0148517. Assignee Hawaii Biotech Inc. Published Jul. 7, 2005.
  • Lockwood, S. F., O’Malley, S., Jackson, H. L., Nadolski, G. 2005. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation. US 2005/0261254. Assignee Hawaii Biotech Inc. Published Nov. 24, 2005.
  • Lockwood, S. F., O’Malley, S., Jackson, H. L., Nadolski, G. 2006. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation. US 2006/0058269. Assignee Hawaii Biotech Inc. Published Mar. 16, 2006.
  • Lockwood, S. F., Tang, P. C., Nadolski, G. T., Jackson, H. L., Fang, Z., Du, Y., Yang, M., Geiss, W. B., Williams, R., Burdick, D. C. 2006. Methods for the synthesis of zeazanthin. US 2006/0088905. Assignee Hawaii Biotech Inc. Published Apr. 27, 2006.
  • Lockwood, S. F., Tang, P. C., Nadolski, G. T., Jackson, H. L., Fang, Z., Du, Y., Yang, M., Geiss, W. B., Williams, R., Burdick, D. C. 2006. Methods for the synthesis of chiral dihydroxy ketone intermediates useful for the chiral synthesis of carotenoids. US 2006/0111580. Assignee Hawaii Biotech Inc. Published May 25, 2006.
  • Lockwood, S. F., Tang, P. C., Nadolski, G., Jackson, H. L., Fang, Z., Du, Y., Yang, M., Geiss, W., Williams, R., Burdick, D. 2006. Methods for the synthesis of lutein. US 2006/155150. Assignee Hawaii Biotech Inc. Published Jul. 13, 2006.
  • Lockwood, S. F., Tang, P. C., Nadolski, G., Jackson, H. L., Fang, Z., Du, Y., Yang, M., Geiss, W., Williams, R., Burdick, D. 2006. Methods for the synthesis of unsaturated ketone intermediates useful for the synthesis of carotenoids. US 2006/167319. Assignee Hawaii Biotech Inc. Published Jul. 27, 2006.
  • Lockwood, S. F., Tang, P. C., Nadolski, G., Jackson, H. L., Fang, Z., Du, Y., Yang, M., Geiss, W., Williams, R., Burdick, D. 2006. Methods for the synthesis of chiral dihydroxy intermediates useful for the chiral synthesis of carotenoids. US 2006/178538. Assignee Hawaii Biotech Inc. Published Aug. 10, 2006.
  • Lockwood, S. F., Tang, P. C., Nadolski, G., Jackson, H. L., Fang, Z., Du, Y., Yang, M., Geiss, W., Williams, R., Burdick, D. 2005. Methods for the synthesis of astaxanthin. US 2006/183185. Assignee Hawaii Biotech Inc. Published Aug. 17, 2006.
  • Lockwood, S. F., Tang, P. C., Nadolski, G., Jackson, H. L., Fang, Z., Du, Y., Yang, M., Geiss, W., Williams, R., Burdick, D. 2006. Methods for the synthesis of astaxanthin. US 2006/183947. Assignee Hawaii Biotech Inc. Published Aug. 17, 2006.
  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L. M., Jackson, H., Nadolski, G. 2006. Structural carotenoid analogs for the inhibition and amelioration of disease. US 2006/229446. Assignee Hawaii Biotech Inc. Published Oct. 12, 2006.
  • Lockwood, S. F., Nadolski, G. 2006. Carotenoids, carotenoid analogs, or carotenoid derivatives for the treatment of visual disabilities. US 2006/270589. Assignee Hawaii Biotech, Inc. Published Nov. 30, 2006.
  • Lockwood, S. F., Nadolski, G. 2006. Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof. US 2006/270590. Assignee Hawaii Biotech, Inc. Published Nov. 30, 2006.
  • Lockwood, S. F., Nadolski, G., Frey, D. A., McLaws, M., King, T. J., Burdick, D. 2006. Carotenoids, carotenoid analogs, or carotenoid derivatives for the treatment of proliferative disorders. US 2006/276372. Assignee Hawaii Biotech, Inc. Published Dec. 7, 2006.
  • Lockwood, S. F., Tang, P. C., Nadolski, G., Jackson, H. L., Fang, Z., Du, Y., Yang, M., Geiss, W., Williams, R., Burdick, D. 2006. Methods for synthesis of carotenoids, including analogs, derivatives, and synthetic and biological intermediates. US 2006/293545. Assignee Hawaii Biotech, Inc. Published Dec. 28, 2006.
  • Lockwood, S. F., Nadolski, G. 2006. Water-dispersible carotenoids, including analogs and derivatives. US 2007/15735. Assignee Hawaii Biotech, Inc. Published Jan. 18, 2007.
  • Lockwood, S. F.  2007.  Structural carotenoid analogs or derivatives for the modulation of systemic and/or target organ redox status.  US 2007/0238793.  Assignee Hawaii Biotech, Inc.  Published Oct. 11, 2007.
  • Lockwood, S. F., Tang, P. C., Nadolski, G., Jackson, H. L., Fang, Z., Du, Y., Yang, M., Geiss, W., Williams, R., Burdick, D., Braun, C.  2008.  Methods for synthesis of carotenoids, including analogs, derivatives, and synthetic and biological intermediates.  US 2008/0221377.  Assignee Cardax Pharmacetuicals, Inc.  Published Sep. 11, 2008.
  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L. M., Jackson, H., Nadolski, G.  Canadien Patent Application CPA 2,495,167.  Analogues de carotenoides structuraux pour l’inhibition et la reduction de maladie.  Assignee Hawaii Biotech, Inc.  PCT publication date Feb. 5, 2004.
  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L. M., Jackson, H., Nadolski, G.  European Patent Office EP 1,532,108.  Structural carotenoid analogs for the inhibition and amelioration of disease.  Assignee Hawaii Biotech, Inc.  EP publication date May 25, 2005.
  • Lockwood, S. F., O’Malley, S., Watumull, D. G., Hix, L. M., Jackson, H., Nadolski, G.  Patent Cooperation Treaty WO 2004/011423.  Structural carotenoid analogs for the inhibition and amelioration of disease.  Assignee Hawaii Biotech, Inc.  WO publication date Feb. 5, 2004.
  • Lockwood, S. F., O’Malley, S., Jackson, H., Nadolski, G.  Patent Cooperation Treaty WO 2005/102356.  Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation.  Assignee Hawaii Biotech, Inc.  WO publication date Nov. 3, 2005.
  • Lockwood, S. F., Tang, P. C., Nadolski, G., Fang, Z., Du, Y., Geiss, W., Williams, R., Burdick, D.  Patent Cooperation Treaty WO 2006/039685.  Methods for synthesis of chiral intermediates of carotenoids, carotenoid analogs, and carotenoid derivatives.  Assignee Hawaii Biotech, Inc.  WO publication date Apr. 13, 2006.

Manufacturing


Pharmasourcing

Leveraging An Effective Paradigm

Pharmasourcing at Baselodge Group began in 2007 to accommodate today’s dynamic pharmaceutical and nutraceutical landscape, in which drug discovery & development companies may need to leverage their core expertise to provide the infrastructure, personnel, and other resources necessary to bring a product to market. Similarly, as a sea change occurs in the manufacturing sector for large manufacturers with excess capacity, or dedicated outsource providers seeking to grow their revenues, a novel approach to connecting these members of the supply chain was introduced into this space.

Borrowing from the mature—and established—electronics manufacturing services paradigm at Baselodge (founded by president Mark L. Casey in 2006), the company is currently in the process of providing the education and information necessary to both principals and potential customers for the mutual benefit of these sometimes disconnected members of the supplement and drug development continuum.

Our success in pharmasourcing at Baselodge Group will be based on our ability to establish business relationships among potential partners whereby both customer and supplier recognize the value of the mutually beneficial relationship. In its early stages, this will require education of customers and service suppliers of the value of the manufacturer’s representative paradigm that works exceedingly well in the analogous space of electronics manufacturing services.

Geography

Based in Austin, TX, Baselodge Group primarily serves customers in Texas, Oklahoma, Arkansas, Louisiana, and New Mexico.

Electronics Manufacturing Service Area

Line Card

South Bay Circuits, Inc

South Bay CircuitsSouth Bay Circuits is based in Chandler, AZ and provides high quality printed circuit fabrication, electronics assembly, backplane assembly, card cage services, & testing. Manufacturing in USA.

Fedcor Design

Fedcor Design

Fedcor Design is a US-based sourcing company that provides global manufacturing services for the production of custom keypads, membrane switches, elastomeric connectors, flex circuits, mesh screen, sheet metal, and machined parts.

ManuTech Limited

ManuTech Limited is an American company with international manufacturing services. An ISO 9001-2000 manufacturer providing OEMs with extensive electronic assembly capabilities, electro-mechanical assembly, metal stamping, plastics tooling and molding, wire harnesses, cable assemblies, and more. The outsourcing of manufacturing provides OEMs with a faster time to market, decreased capital expenditures, lower fixed costs, higher return on invested capital, greater focus on R&D activities and marketing, easy access to leading-edge manufacturing technologies, and improved materials management and logistics.

Control Products Corporation

Control Products CorporationControl Products Corporation is based in Grafton, WI and provides electronics assembly, potting, electro-mechanical assembly, & final assembly. Manufacturing in USA.

In association with T-Tec Sales

Caprock Manufacturing

Caprock ManufacturingFounded in 1983, Caprock Manufacturing is a privately held custom manufacturer of plastic injection molded products and assemblies for the OEM market. Vertically integrated services include product design, prototyping, mold making and a wide range of finishing processes. This depth of capabilities enables a customer to procure a complete product, including EMI/RFI shielding assembly from a single supplier.

Chicago White Metal

Chicago White Metal CastingFounded as a custom die caster in a Chicago loft in 1937 by Walter Treiber, Sr. and Samuel Gullo, CWM operates today under third-generation Treiber family management from a modern 136,000 sq. ft. facility in Bensenville, Illinois, near Chicago’s O’Hare International Airport. CWM is rated by Dun & Bradstreet as 3A2.With over 70 years of innovation, CWM is delivering high-tech die castings in Al, Mg and Zn for a wide range of applications: to net- and near net-shape with thin walls and critical tolerances that newer so-called metal-molding processes cannot consistently match.

Webber Electronics

Webber ElectronicsWebber Electronics Power Cords and Cordsets are designed for use in both consumer and industrial applications. Our power cords are ideal for computers, appliances, medical devices, business machines, power tools and other instrumentation and communication equipment.Our broad offering of International and North American power cords includes cords in both standard and custom configurations. We offer same day shipments from one of our regional distribution centers.


Manufacturing

We have carefully selected contract manufacturers that possess a high degree of integrity in the way they conduct business. Our reputation is inextricably intertwined with the performance and procedures of our manufacturers. Baselodge Group offers the following services:

  • Printed circuit board (PCB) fabrication - quick turn & standard turn
  • Printed circuit board assembly (PCBA) - prototype & production volumes (USA & China)
  • Flex circuits
  • Electro-mechanical assembly
  • Sheet metal
  • Plastic injection molding & tooling
  • Thixomolding
  • Keypads & membrane switches
  • Elastomeric connectors
  • Cable assemblies
  • Final system integration (box-build)
  • Electrical & mechanical engineering
  • Electronic components
  • Die casting
  • Power cords and cordsets

Our line card link at left provides a brief description of our manufacturers as well as links to their websites.

Electronics Manufacturing